MYO Company Profile and Key Details

MYO has shown mixed momentum, losing -0.52% over the past week and -4.86% over the past quarter, though year-to-date performance is up 7.68%. Short-term trend indicators are bullishly aligned (SMA20 -1.43%, SMA50 -12.77%, SMA200 -45.43%). The stock’s 14-day RSI is 45.7 (neutral), while the ATR of 0.07 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -87.61% below its high and over 21.78% above its low. Average 10-day trading volume of 332.01 thousand shares is below the 3-month average of 399.49 thousand, indicating normal recent market interest.

Myomo, Inc. has 38.44 million shares outstanding. The public float is 27.66 million shares, elevated short interest at 12.93% of float. This equals 4.77 million shares. The short ratio is 10.12 days. Institutional investors hold 55.02% of the float. Insiders own 6.99%. GUDONIS PAUL R holds 1.26 million shares, KIRK THOMAS F has 553.86 thousand shares and HENRY DAVID A has 352.19 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Myomo, Inc. generated EPS of -$0.29 over the past year. Five-year average earnings growth is 62.04%. Wall Street analysts project EPS growth of -4.96% annually over the next five years. The latest quarter delivered EPS of -$0.09. The next quarter is forecast at -$0.09. Next year's EPS is expected at $37.50. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $10.50 to $5.00. The high target offers 1165.06% upside. The low target suggests 502.41% downside. The mean target is $8.50. This offers 924.1% upside. Myomo, Inc. earnings surprise history is a mixed track record. The quarter that ended November 10, 2025, missed forecasts by -21.04%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include -57.13% in August 06, 2024.

Myomo, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.88. This means the shares are trading below this model’s fair value.

Myomo, Inc. (AMEX:MYO) closed at $0.83 USD, gaining $0.01 (0.80%) from the previous close of $0.82. The stock is currently mid-range between its 52-week high and low $0.60 and $4.99. With a market capitalization of about $32.00 million, Myomo, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.16). Key stats such as the average daily volume over the past year has been around 389.64 thousand shares, volume is running light vs its 52-week average. Headquartered in Burlington, MA, Myomo, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Paul R. Gudonis, the company employs approximately 184 people and listed since June 12, 2017. Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States.

Myomo, Inc. trades at a P/E ratio of -2.24, slightly below the S&P 500 average, with a price-to-sales ratio of 0.78 and a price-to-book ratio of 3.06 trading at moderately above to book value. The P/FCF stands at -1.77, also above market averages.

Myomo, Inc. (AMEX:MYO) shares are flat 7.68% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Myomo, Inc. trading at a premium to the broader market with a P/E of -2.24. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $8.24, suggesting 891.58% upside. Our AI forecast model points to short-term strength (11.91% over two weeks), a medium-term fall (-50.66% over three months), and a longer-term gain (8.3% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Myomo, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 11.91%, with price expected at $0.93 by May 07, 2026, within a range of $0.89 to $0.97 3-Month Outlook: Projected fall of -50.66%, reaching $0.41 by July 22, 2026, with a range of $0.33 to $0.50. 1-Year Outlook: Projected gain of 8.3%, with price at $0.90 by April 23, 2027, within a range of $0.00 to $0.00.